| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
MycCDK2Neoplasia (Carcinogenesis)RNA (MicroRNA)Genetic instabilityWnt beta Catenin TCFLKB1HIF1alpha und HIF1 (BASKET)Implantation (Development)RibosomeBystinDNA (Transcription)P TEFbBRD4H2BubH3S10SKIPSpt6Iws1REF1 AlyNeoplasia (Invasion and metastasis)MTDH Metadherin AEG1 Astrocyte Elevated Gene1NeuroblastomaPolyaminesCell senescenceWarburg effectNeoplasia (Dormancy)| 1 | 1999 | Gene transcription through Myc family members in eukaryotic cells. | 
| + | - | nl | Jpn J Pharmacol 80(2):103-9 (1999) |
| 2 | 1992 | Regulation of Myc: Max complex formation and its potential role in cell proliferation. | 
| + | - | nl | Tohoku J Exp Med 168(2):195-202 (1992) |
| 3 | 2002 | c-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases? | 
| + | - | nl | Neoplasia 4(3):185-90 (2002) |
| 4 | 2007 | Myc goes global: new tricks for an old oncogene. | 
| + | - | nl | Cancer Res 67(11):5061-3 (2007) |
| 5 | 2009 | c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. | 
| + | - | nl | Oncogene 28(27):2485-91 (2009) |
| 6 | 2002 | The proto-oncogene c-myc in hematopoietic development and leukemogenesis. | 
| + | - | nl | Oncogene 21(21):3414-21 (2002) |
| 7 | 1999 | MYC oncogenes and human neoplastic disease. | 
| + | - | nl | Oncogene 18(19):3004-16 (1999) |
| 8 | 1999 | The v-myc oncogene. | 
| + | - | nl | Oncogene 18(19):2997-3003 (1999) |
| 9 | 1999 | The role of c-myc in cellular growth control. | 
| + | - | nl | Oncogene 18(19):2988-96 (1999) |
| 10 | 1999 | Mechanisms of apoptosis by c-Myc. | 
| + | - | nl | Oncogene 18(19):2967-87 (1999) |
| 11 | 1999 | The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. | 
| + | - | nl | Oncogene 18(19):2955-66 (1999) |
| 12 | 1999 | New Myc-interacting proteins: a second Myc network emerges. | 
| + | - | nl | Oncogene 18(19):2942-54 (1999) |
| 13 | 1999 | Mysterious liaisons: the relationship between c-Myc and the cell cycle. | 
| + | - | nl | Oncogene 18(19):2934-41 (1999) Obaya AJ |
| 14 | 1999 | Myc-mediated transformation: the repression connection. | 
| + | - | nl | Oncogene 18(19):2925-33 (1999) |
| 15 | 1999 | The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. | 
| + | - | nl | Oncogene 18(19):2916-24 (1999) Cole MD |
| 16 | 1998 | The proto-oncogene c-myc and apoptosis. | 
| + | - | nl | Oncogene 17(25):3351-7 (1998) |
| 17 | 2009 | Key signalling nodes in mammary gland development and cancer: Myc. | 
| + | - | nl | Breast Cancer Res 11(5):210 (2009) |
| 18 | 1998 | The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. | 
| + | - | nl | FASEB J 12(9):633-51 (1998) |
| 19 | 1992 | Function of the c-Myc oncoprotein. | 
| + | - | nl | FASEB J 6(12):3065-72 (1992) |
| 20 | 2006 | Of Myc and Mnt. | 
| + | - | nl | J Cell Sci 119(Pt 2):208-16 (2006) |
| 21 | 2007 | c-Myc blazing a trail of death: coupling of the mitochondrial and death receptor apoptosis pathways by c-Myc. | 
| + | - | nl | Cell Cycle 6(20):2464-72 (2007) |
| 22 | 2004 | The life cycle of C-myc: from synthesis to degradation. | 
| + | - | nl | Cell Cycle 3(9):1133-7 (2004) |
| 23 | 2003 | E2F1 and c-Myc in cell growth and death. | 
| + | - | nl | Cell Cycle 2(4):333-8 (2003) |
| 24 | 2003 | c-Myc oncoprotein: cell cycle-related events and new therapeutic challenges in cancer and cardiovascular diseases. | 
| + | - | nl | Cell Cycle 2(4):325-8 (2003) |
| 25 | 2000 | c-Myc in breast cancer. | 
| + | - | nl | Endocr Relat Cancer 7(3):143-64 (2000) |
| 26 | 2008 | Myc's broad reach. | 
| + | - | nl | Genes Dev 22(20):2755-66 (2008) |
| 27 | 2003 | Reconstructing MYC. | 
| + | - | nl | Genes Dev 17(9):1071-7 (2003) |
| 28 | 1990 | New light on Myc and Myb. Part I. Myc. | 
| + | - | nl | Genes Dev 4(12A):2025-35 (1990) |
| 29 | 2006 | The ins and outs of MYC regulation by posttranslational mechanisms. | 
| + | - | nl | J Biol Chem 281(46):34725-9 (2006) |
| 30 | 1999 | c-Myc target genes involved in cell growth, apoptosis, and metabolism. | 
| + | - | nl | Mol Cell Biol 19(1):1-11 (1999) |
| 31 | 2007 | "Myc'ed messages": myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron. | 
| + | - | nl | PLoS Genet 3(8):e146 (2007) |
| 32 | 2007 | HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. | 
| + | - | nl | Cancer Cell 12(2):108-13 (2007) |
| 33 | 2005 | The great MYC escape in tumorigenesis. | 
| + | - | nl | Cancer Cell 8(3):177-8 (2005) |
| 34 | 2002 | Myc-Is this the oncogene from Hell? | 
| + | - | nl | Cancer Cell 1(5):406-8 (2002) |
| 35 | 2004 | Myc: a weapon of mass destruction. | 
| + | - | nl | Cell 117(2):153-6 (2004) |
| 36 | 2008 | Why myc? An unexpected ingredient in the stem cell cocktail. | 
| + | - | nl | Cell Stem Cell 2(1):18-21 (2008) |
| 37 | 1999 | Cell growth: downstream of Myc - to grow or to cycle? | 
| + | - | nl | Curr Biol 9(24):R936-8 (1999) |
| 38 | 1996 | Cell cycle: on target with Myc. | 
| + | - | nl | Curr Biol 6(12):1553-6 (1996) |
| 39 | 2001 | Making decisions through Myc. | 
| + | - | nl | FEBS Lett 490(3):153-62 (2001) |
| 40 | 2010 | Cdk2: a key regulator of the senescence control function of Myc. | 
| + | - | nl | Aging (Albany NY) 2(4):244-50 (2010) |
| 41 | 2011 | c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis. | 
| + | - | nl | Cancer Biol Ther 11(7):615-26 (2011) |
| 42 | 2010 | Regulation of Myc by miR-34c: A mechanism to prevent genomic instability? | 
| + | - | nl | Cell Cycle 9(14):2726-30 (2010) |
| 43 | 2010 | A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways. | 
| + | - | nl | Cell Cycle 9(9):1722-8 (2010) |
| 44 | 2007 | Feedback regulation of c-Myc by ribosomal protein L11. | 
| + | - | nl | Cell Cycle 6(22):2735-41 (2007) |
| 45 | 2007 | Turning the tables: Myc activates Wnt in breast cancer. | 
| + | - | nl | Cell Cycle 6(21):2625-7 (2007) |
| 46 | 2009 | 3D view to tumor suppression: Lkb1, polarity and the arrest of oncogenic c-Myc. | 
| + | - | nl | Cell Cycle 8(5):716-24 (2009) |
| 47 | 2008 | Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation. | 
| + | - | nl | Cell Death Differ 15(4):672-7 (2008) |
| 48 | 2008 | The role of bystin in embryo implantation and in ribosomal biogenesis. | 
| + | - | nl | Cell Mol Life Sci 65(1):92-9 (2008) |
| 49 | 2008 | The multi-tasking P-TEFb complex. | 
| + | - | nl | Curr Opin Cell Biol 20(3):334-40 (2008) |
| 50 | 2010 | The ups and downs of Myc biology. | 
| + | - | nl | Curr Opin Genet Dev 20(1):91-5 (2010) |
| 51 | 2009 | MYC-induced cancer cell energy metabolism and therapeutic opportunities. | 
| + | - | nl | Clin Cancer Res 15(21):6479-83 (2009) |
| 52 | 2009 | The multifaceted role of MTDH/AEG-1 in cancer progression. | 
| + | - | nl | Clin Cancer Res 15(18):5615-20 (2009) |
| 53 | 2009 | Disrupting polyamine homeostasis as a therapeutic strategy for neuroblastoma. | 
| + | - | nl | Clin Cancer Res 15(19):5956-61 (2009) |
| 54 | 2010 | Tipping the balance: Cdk2 enables Myc to suppress senescence. | 
| + | - | nl | Cancer Res 70(17):6687-91 (2010) |
| 55 | 2010 | Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. | 
| + | - | nl | Cancer Res 70(3):859-62 (2010) |
| 56 | 2005 | Tumor dormancy and MYC inactivation: pushing cancer to the brink of normalcy. | 
| + | - | nl | Cancer Res 65(11):4471-4 (2005) |
| 57 | 2009 | The role of Myc-induced protein synthesis in cancer. | 
| + | - | nl | Cancer Res 69(23):8839-43 (2009) |
| 58 | 2009 | Acting locally and globally: Myc's ever-expanding roles on chromatin. | 
| + | - | nl | Cancer Res 69(19):7487-90 (2009) |